Home › Kanser sa Dugo › North Carolina › Durham
Pag-aaral pangklinika para sa Kanser sa Dugo sa Durham, NC
16 pag-aaral para sa Kanser sa Dugo ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Durham (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Nagre-recruitObservasyonal na pag-aaral
- Duke University Medical Center, Durham
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Nagre-recruitPhase 3
- Duke Cancer Center ( Site 0028), Durham
- University of North Carolina at Chapel Hill ( Site 0040), Chapel Hill · 10 mi ang layo
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Durham VA Medical Center, Durham
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Nagre-recruitPhase 3
- Quetzal Site 27, Chapel Hill · 10 mi ang layo
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Nagre-recruitPhase 3
- Duke University, Durham
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Nagre-recruitPhase 1/2
- UNC School of Medicine, Division of Hematology, Chapel Hill · 10 mi ang layo
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Nagre-recruitPhase 3
- Duke University Medical Center, Durham
- University of North Carolina, Chapel Hill, Chapel Hill · 10 mi ang layo
DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
Nagre-recruit
- Lineberger Comphrehensive Cancer Center at University of North Carolina, Chapel Hill · 10 mi ang layo
PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
Nagre-recruitPhase 2
- Lineberger Cancer, Chapel Hill · 10 mi ang layo
Mindfulness Intervention for Sleep Disturbance and Symptom Management in Hematologic Cancer Patients During and After Inpatient Treatment
Nagre-recruit
- 2400 Pratt Street, Durham
Implementation of an Oral Chemotherapy Adherence Intervention
Nagre-recruit
- UNC Chapel Hill, Chapel Hill · 10 mi ang layo
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Nagre-recruitObservasyonal na pag-aaral
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi ang layo
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Nagre-recruitPhase 1
- University of North Carolina, Chapel Hill · 10 mi ang layo
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Nagre-recruitPhase 1/2
- Duke University Medical Center, Duke Cancer Center, Durham
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Nagre-recruitPhase 1
- Duke Blood Cancer Center, Durham
HMCT/CT2401: Abatacept GVHD Prophylaxis Following Omidubicel HCT
Nagre-recruitMaagang Phase 1
- Duke University Health System, Durham
Pag-aaral para sa Kanser sa Dugo sa ibang lungsod
- Houston, TX46 pag-aaral
- New York City, NY26 pag-aaral
- Boston, MA25 pag-aaral
- Washington, DC19 pag-aaral
- Seattle, WA18 pag-aaral
- Baltimore, MD18 pag-aaral
- Los Angeles, CA17 pag-aaral
- Chicago, IL15 pag-aaral
- Philadelphia, PA14 pag-aaral
- Nashville, TN13 pag-aaral
- Edison, NJ13 pag-aaral
- Columbus, OH13 pag-aaral
Iba pang pag-aaral sa Durham
- Kanser sa Suso64 pag-aaral
- Kanser (lahat ng uri)58 pag-aaral
- Non-Small Cell Lung Cancer39 pag-aaral
- Multiple Myeloma37 pag-aaral
- Acute Myeloid Leukemia33 pag-aaral
- Metastatic Cancer33 pag-aaral
- Kanser sa Prostate32 pag-aaral
- Kanser sa Baga32 pag-aaral
- Colorectal Cancer28 pag-aaral
- Kanser sa Ovary27 pag-aaral
- Chronic Lymphocytic Leukemia27 pag-aaral
- Pagkabigo ng Puso26 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.